Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
在对伊布替尼和/或阿卡替尼不耐受的B细胞恶性肿瘤患者中,一项关于泽布替尼II期研究的基因组图谱
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2023.283861
Xu, Linlin; Shadman, Mazyar; Flinn, Ian W; Levy, Moshe Y; Porter, Ryan; Burke, John M; Zafar, Syed F; Cultrera, Jennifer L; Misleh, Jamal; Kingsley, Edwin C; Yimer, Habte A; Freeman, Benjamin; Chaudhry, Arvind; Tumula, Praveen K; Gandhi, Mitul D; Crescenzo, Rocco; By, Kunthel; Cohen, Aileen; Chen, Dih-Yih; Idoine, Adam; Manda, Sudhir; Sharman, Jeff P; Ramakrishnan, Vanitha